Quick answers
- What is Felodipine used for?
- The FDA-approved label (Felopdipine, A-S Medication Solutions, August 7, 2024) says: “Felodipine Extended-release Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. …” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
- Does Felodipine have a boxed warning?
- No. None of the 28 FDA labels we found for this medicine has a boxed warning.
- Is there a shortage of Felodipine?
- The FDA drug shortage list shows “To be discontinued” for a product of this medicine (updated October 7, 2026). Ask your pharmacist about alternatives.
- Has Felodipine been recalled?
- FDA enforcement reports list 1 recall of products of this medicine; the newest started October 23, 2020 (Class III). A recall usually concerns specific lots, not every product.
- Who makes Felodipine?
- 14 companies list prescription products of Felodipine in the FDA NDC Directory, including Bryant Ranch Prepack, Rising Pharma Holdings, Inc. and Chartwell RX, LLC.
What Felodipine is used for
Quoted from the “Indications and Usage” section of the FDA-approved label.
Felodipine Extended-release Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including felodipine. …
— FDA label: Felopdipine, A-S Medication Solutions, effective August 7, 2024. Read the full label on DailyMed →
The FDA has 28 labels for products of this medicine (different makers and forms); uses can differ between them. Check the label that comes with your own medicine.
This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Conditions named on the label
These condition names appear word for word in the label’s “Indications and Usage” text (matched with a reviewed table). Each page lists hospitals whose own websites name the condition.
Related medical specialties
Boxed warning
A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.
The label quoted above has no boxed warning.
0 of 28 FDA labels for this medicine have a boxed warning.
Forms and how it is given
| Dosage forms | Tablet, extended release · Tablet, film coated, extended release · Tablet, film coated |
|---|---|
| Route | Oral |
| Prescription products | 53 in the FDA NDC Directory |
| Brand names | Felopdipine |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| felodipine 10 mg tablet, extended release | Generic | $0.1303 per tablet |
| felodipine 10 mg tablet, film coated | Generic | $0.1303 per tablet |
| felodipine 10 mg tablet, film coated, extended release | Generic | $0.1303 per tablet |
| felodipine 2.5 mg tablet, extended release | Generic | $0.1203 per tablet |
| felodipine 2.5 mg tablet, film coated | Generic | $0.1203 per tablet |
| felodipine 2.5 mg tablet, film coated, extended release | Generic | $0.1203 per tablet |
| felodipine 5 mg tablet, extended release | Generic | $0.1222 per tablet |
| felodipine 5 mg tablet, film coated | Generic | $0.1222 per tablet |
| felodipine 5 mg tablet, film coated, extended release | Generic | $0.1222 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list this medicine
Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.
- Bryant Ranch Prepack15 products
- Rising Pharma Holdings, Inc.3 products
- Chartwell RX, LLC3 products
- Aurobindo Pharma Limited3 products
- Yiling Pharmaceutical, Inc.3 products
- Par Health USA, LLC3 products
- Glenmark Pharmaceuticals Inc., USA3 products
- Proficient Rx LP3 products
- Westminster Pharmaceuticals, LLC3 products
- Torrent Pharmaceuticals Limited3 products
- Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.3 products
- A-S Medication Solutions3 products
- Carlsbad Technology, Inc.3 products
- Golden State Medical Supply, Inc.2 products
FDA approval history
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
Generic approvals (7)
- ANDA090365Glenmark Pharms Ltd · December 17, 2010
- ANDA200815Ph Health · October 28, 2011
- ANDA202170Torrent Pharms Ltd · November 28, 2011
- ANDA203417Aurobindo Pharma Ltd · January 17, 2013
- ANDA201964Heritage · November 8, 2013
- ANDA210847Pharmobedient · October 26, 2018
- ANDA204800Yung Shin Pharm · April 29, 2019
Shortage status
To be discontinued · updated October 7, 2026 · first posted October 7, 2026
| Product | Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28) |
|---|---|
| Company | Par Health, USA LLC |
Ask your pharmacist whether your product is affected and what the options are.
Recalls
From FDA enforcement reports, matched by the product’s NDC code. A recall usually covers specific lots only: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
October 23, 2020 · Class III · Terminated · D-0108-2021
Failed impurities/ degradation specifications: Out of specification impurity results were observed during routine testing of stability samples for the impurity Felodipine Related compound A
Felodipine Extended Release Tablets, USP 10 mg,100-count bottle, Rx only, Distributed by: Heritage Pharmaceuticals Inc. East Brunswick, NJ 08816 Made in India, NDC 23155-050-01 — Heritage Pharmaceuticals Inc
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Official identifiers
| RxCUI (RxNorm) | 402695, 402696, 402698 |
|---|---|
| SPL set ID of the quoted label | 129c48eb-29f2-462b-ad8a-b3bf1b193115 |
| FDA labels (SPL) | 28 |
| FDA applications | 7 ANDA |
| Active ingredients (FDA) | FELODIPINE |
Sources
- FDA-approved label on DailyMed (National Library of Medicine) — Felopdipine, A-S Medication Solutions, effective August 7, 2024; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →